Literature DB >> 9170210

TGF-beta latency: biological significance and mechanisms of activation.

P E Gleizes1, J S Munger, I Nunes, J G Harpel, R Mazzieri, I Noguera, D B Rifkin.   

Abstract

Transforming growth factor (TGF-) beta is secreted as a latent complex in which the mature growth factor remains associated with its propeptide. In order to elicit a biological response, the cytokine must be released from the latent complex, a process termed latent TGF-beta activation or TGF-beta formation. Although latent TGF-beta activation is a critical step in the regulation of its activity, little is known about the molecular mechanisms that lead to the production of active TGF-beta. In this article, we present an overview of the data available on this topic, and we propose a tentative model for the mechanism of TGF-beta formation based upon the observations with different cell systems and on recent findings on the structure of the latent TGF-beta complex.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9170210     DOI: 10.1002/stem.150190

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  71 in total

1.  PAI-1, fibrosis, and the elusive provisional fibrin matrix.

Authors:  D J Loskutoff; J P Quigley
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

2.  Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation.

Authors:  Mai-Lan N Huynh; Valerie A Fadok; Peter M Henson
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

Review 3.  Animal models for scleroderma: an update.

Authors:  Yan Zhang; Anita C Gilliam
Journal:  Curr Rheumatol Rep       Date:  2002-04       Impact factor: 4.592

4.  Endothelial Cell Vascular Smooth Muscle Cell Co-Culture Assay For High Throughput Screening Assays For Discovery of Anti-Angiogenesis Agents and Other Therapeutic Molecules.

Authors:  George A Truskey
Journal:  Int J High Throughput Screen       Date:  2010-10-01

5.  SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system.

Authors:  Barbara J Schiemann; Jason R Neil; William P Schiemann
Journal:  Mol Biol Cell       Date:  2003-06-27       Impact factor: 4.138

6.  Exercise-induced changes in circulating levels of transforming growth factor-beta-1 in humans: methodological considerations.

Authors:  Katja Heinemeier; Henning Langberg; Michael Kjaer
Journal:  Eur J Appl Physiol       Date:  2003-07-09       Impact factor: 3.078

7.  Processing of anti-mullerian hormone regulates receptor activation by a mechanism distinct from TGF-beta.

Authors:  Nathalie di Clemente; Soazik P Jamin; Alexey Lugovskoy; Paul Carmillo; Christian Ehrenfels; Jean-Yves Picard; Adrian Whitty; Nathalie Josso; R Blake Pepinsky; Richard L Cate
Journal:  Mol Endocrinol       Date:  2010-09-22

8.  Pro- and anti-inflammatory cytokines regulate the ERK pathway: implication of the timing for the activation of microglial cells.

Authors:  K Saud; R Herrera-Molina; R Von Bernhardi
Journal:  Neurotox Res       Date:  2005-11       Impact factor: 3.911

9.  The Critical Role of TGF-beta1 in the Development of Induced Foxp3+ Regulatory T Cells.

Authors:  Song Guo Zheng
Journal:  Int J Clin Exp Med       Date:  2008-06-10

10.  Plasminogen activator inhibitor-1 (PAI-1) is cardioprotective in mice by maintaining microvascular integrity and cardiac architecture.

Authors:  Zhi Xu; Francis J Castellino; Victoria A Ploplis
Journal:  Blood       Date:  2009-12-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.